alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 14

- 20219 Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff

- Appellee

v.

JAMES RAY SCALES

,

Defendant

- Appellant

Appeal from the United States District Court for the Southern District of Texas USDC No. 4:12

- CR

- 301

- 1

Before JOLLY, GRAVES, and COSTA, Circuit Judges.

PER CURIAM: *

The attorney appointed to represent James Ray Scales has moved for

leave to withdraw and has filed a brief in accordance with Anders v. California

, 386 U.S. 738 (1967), and United States v. Flores , 632 F.3d 229 (5th Cir. 2011).

Scales h a s not filed a response. We have reviewed counsel’s brie f and the
relevant portions of the record reflected therein. We concur with counsel’s
assessment that the appeal presents no nonfrivolous issue for appellate review.

* Pursuant to 5 TH C IR

. R. 47.5 , the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR

. R. 47.5.4. United States Court of Appeals Fifth Circuit 

### FILED August 1 8 , 2015

Lyle W. Cayce Clerk Case: 14-20219 Document: 00513158337 Page: 1 Date Filed: 08/18/2015No. 14

- 20219

2 Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is

excused from further responsibilities herein, and the APPEAL IS DISMISSED.

See 5 TH C IR

. R. 42.2. Case: 14-20219 Document: 00513158337 Page: 2 Date Filed: 08/18/2015
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS INCLUDED IN ITEM 1 OF FORM 10-Q DATED SEPTEMBER 30, 1996
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                              69
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                      69
<CURRENT-LIABILITIES>                              165
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                        (96)
<TOTAL-LIABILITY-AND-EQUITY>                        69
<SALES>                                              0
<TOTAL-REVENUES>                                 4,526
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  4,468
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,468
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
# L_2019031EN.01010802.xml

| 1.2.2019 | EN | Official Journal of the European Union | L 31/108 |
| --- | --- | --- | --- |

1.2.2019

EN

Official Journal of the European Union

L 31/108

---

Corrigendum to Council Directive (EU) 2018/822 of 25 May 2018 amending Directive 2011/16/EU as regards mandatory automatic exchange of information in the field of taxation in relation to reportable cross-border arrangements

(
  Official Journal of the European Union L 139 of 5 June 2018
  )

On page 8, Article 1(2) (concerning new Article 8ab(12)):

for:

‘12.   Each Member State shall take the necessary measures to require intermediaries and relevant taxpayers to file information on reportable cross-border arrangements the first step of which was implemented between the date of entry into force and the date of application of this Directive. Intermediaries and relevant taxpayers, as appropriate, shall file information on those reportable cross-border arrangements by 31 August 2020.’,

read:

‘12.   Each Member State shall take the necessary measures to require intermediaries and relevant taxpayers to file information on reportable cross-border arrangements the first step of which was implemented between 25 June 2018 and 30 June 2020. Intermediaries and relevant taxpayers, as appropriate, shall file information on those reportable cross-border arrangements by 31 August 2020.’.

---
Alejandro Garcia GONZALEZ, Appellant/Petitioner(s), v. Chad CHRONISTER, Sheriff of Hillsborough County, Florida, Appellee/Respondent(s).

CASE NO.: 2D19-2365

District Court of Appeal of Florida, Second District.

June 27, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
[Federal Register Volume 60, Number 81 (Thursday, April 27, 1995)]
[Unknown Section]
[Page 20795]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10348]



-----------------------------------------------------------------------


DEPARTMENT OF THE TREASURY

Public Information Collection Requirements Submitted to OMB for 
Review

April 18, 1995.
    The Department of Treasury has submitted the following public 
information collection requirement(s) to OMB for review and clearance 
under the Paperwork Reduction Act of 1980, Public Law 96-511. Copies of 
the submission(s) may be obtained by calling the Treasury Bureau 
Clearance Officer listed. Comments regarding this information 
collection should be addressed to the OMB reviewer listed and to the 
Treasury Department Clearance Officer, Department of the Treasury, Room 
2110, 1425 New York Avenue, NW., Washington, DC 20220.

Internal Revenue Service (IRS)

OMB Number: 1545-0687
Form Number: IRS Form 990-T
Type of Review: Revision
Title: Exempt Organization Business Income Tax Return
Description: Form 990-T is needed to compute the section 511 tax on 
unrelated business income of a charitable organization. IRS uses the 
information to enforce the tax.
Respondents: Not-for-profit institutions
Estimated Number of Respondents/Recordkeepers: 37,103
Estimated Burden Hours Per Respondent/Recordkeeper:
    Recordkeeping--65 hr., 19 min.
    Learning about the law or the form--22 hr., 2 min.
    Preparing the form--37 hr., 7 min.
    Copying, assembling, and sending the form to the IRS--3 hr., 45 
min.
Frequency of Response: Annually
Estimated Total Reporting/Recordkeeping Burden: 4,756,234 hours
Clearance Officer: Garrick Shear, (202) 622-3869, Internal Revenue 
Service, Room 5571, 1111 Constitution Avenue, N.W., Washington, DC 
20224
OMB Reviewer: Milo Sunderhauf, (202) 395-7340, Office of Management and 
Budget, Room 10226, New Executive Office Building, Washington, DC 20503
Lois K. Holland,
Departmental Reports Management Officer.
[FR Doc. 95-10348 Filed 4-26-95; 8:45 am]
BILLING CODE 4830-01-P
Case 3:17-cv-00223-RS Document 414-15 Filed 06/18/18 Page 1 of 7
Case 3:17-cv-00223-RS Document 414-15 Filed 06/18/18 Page 2 of 7
Case 3:17-cv-00223-RS Document 414-15 Filed 06/18/18 Page 3 of 7
Case 3:17-cv-00223-RS Document 414-15 Filed 06/18/18 Page 4 of 7
Case 3:17-cv-00223-RS Document 414-15 Filed 06/18/18 Page 5 of 7
Case 3:17-cv-00223-RS Document 414-15 Filed 06/18/18 Page 6 of 7
Case 3:17-cv-00223-RS Document 414-15 Filed 06/18/18 Page 7 of 7
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 1 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 2 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 3 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 4 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 5 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 6 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 7 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 8 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 9 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 10 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 11 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 12 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 13 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 14 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 15 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 16 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 17 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 18 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 19 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 20 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 21 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 22 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 23 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 24 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 25 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 26 of 27
Case 3:16-cv-07157-CRB Document 2 Filed 11/22/16 Page 27 of 27
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                          43,594
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                 6,658
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    189,187
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                        581,894
<ALLOWANCE>                                      8,922
<TOTAL-ASSETS>                                 851,350
<DEPOSITS>                                     678,442
<SHORT-TERM>                                    34,681
<LIABILITIES-OTHER>                              1,468
<LONG-TERM>                                     68,313
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         5,222
<OTHER-SE>                                      63,224
<TOTAL-LIABILITIES-AND-EQUITY>                 851,350
<INTEREST-LOAN>                                 25,310
<INTEREST-INVEST>                                5,875
<INTEREST-OTHER>                                   401
<INTEREST-TOTAL>                                31,586
<INTEREST-DEPOSIT>                              12,676
<INTEREST-EXPENSE>                              16,232
<INTEREST-INCOME-NET>                           15,354
<LOAN-LOSSES>                                    1,276
<SECURITIES-GAINS>                                  96
<EXPENSE-OTHER>                                 14,540
<INCOME-PRETAX>                                  5,628
<INCOME-PRE-EXTRAORDINARY>                       4,066
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,066
<EPS-PRIMARY>                                      .79
<EPS-DILUTED>                                      .77
<YIELD-ACTUAL>                                    4.19
<LOANS-NON>                                      6,085
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                   458
<LOANS-PROBLEM>                                  6,543
<ALLOWANCE-OPEN>                                 8,360
<CHARGE-OFFS>                                      999
<RECOVERIES>                                       285
<ALLOWANCE-CLOSE>                                8,922
<ALLOWANCE-DOMESTIC>                             8,922
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
exv10w25






Exhibit 10.25




BIOGEN IDEC INC.

2006 NON-EMPLOYEE DIRECTORS EQUITY PLAN




AMENDMENT




     The Biogen Idec Inc. 2006 Non-Employee Directors Equity Plan (“the Plan”) is hereby amended as
follows:


In paragraph (b) of Section 4 (“Stock Subject to the Plan”), the words “with respect to dividends
or distributions of cash or other non-stock property” are hereby added immediately after the words
“unless otherwise determined by the Committee in its sole and absolute discretion”.




Date: October 13, 2008
Amendment No. 6 to ARCA 2004 Stock Incentive Plan



 Exhibit 10.7 
 AMENDMENT NO. 6 
 TO THE ARCA DISCOVERY, INC. 
 2004 STOCK INCENTIVE PLAN 
 The ARCA Discovery, Inc.
2004 Stock Incentive Plan (as amended, the “Plan”) is hereby amended as set forth below: 
 1. The first sentence of Section 4 is hereby
deleted and replaced with the following sentence: 
 Subject to adjustment as provided in Section 15 hereof, the number of shares
of Stock available for issuance under the Plan shall be 6,756,550. 
 The remaining sentences of Section 4 shall not be amended. 
 2. Capitalized terms as used in this Amendment No. 6 (this “Amendment”) and not otherwise defined in this Amendment, shall have the meanings
assigned to them in the Plan. The Plan shall otherwise be unchanged by this Amendment. 
 * * * * * 







 This Amendment was duly adopted by the board of directors of ARCA biopharma, Inc. by unanimous written
consent on January 22, 2009, and approved by the written consent of the stockholders of ARCA biopharma, Inc. on January 22, 2009, in accordance with Section 16.2 of the Plan. 
  

			
	ARCA biopharma, Inc.
		
	By:	 	 /s/ Christopher D. Ozeroff

		 	Christopher D. Ozeroff, Secretary
Problèmes de 

sommeil

Bureau de la santé des femmes de la FDA 

www.fda.gov/womens

Faits de base sur le sommeil

La plupart des adultes ont besoin de 7 à 8 heures 

de sommeil chaque nuit. Tout le monde n’a pas le 

sommeil dont il a besoin.

De temps en temps, vous pouvez avoir du mal à 

dormir en raison de:

• Stress

• Problèmes de santé et médicaments

• Longues heures de travail / travail posté

• Lumière ou bruit

• Boire de l’alcool ou manger trop près de l’heure du 

coucher

Si vous avez du mal à vous endormir ou à rester 

endormi la plupart des nuits, vous pouvez avoir un 

problème de sommeil appelé insomnie.

Certaines personnes ont des problèmes de sommeil 

plus graves. Discutez avec votre médecin si vous :

• Vous endormez pendant la journée

• Ronflez ou faites des bruits d’étouffement pendant 

votre sommeil

• Avez des sentiments étranges dans vos jambes ou 

si vous vous sentez le besoin de bouger vos jambes

Médicaments pour vous aider à dormir

Il existe des médicaments qui peuvent vous 

aider à vous endormir ou à rester endormi. Vous 

avez besoin d’une ordonnance médicale pour 

certains somnifères. Vous pouvez obtenir d’autres 

médicaments en vente libre sans ordonnance.

Ordonnance

Les somnifères sur ordonnance fonctionnent bien 

pour de nombreuses personnes, mais ils peuvent 

provoquer des effets secondaires graves.

• Discutez avec votre médecin de tous les risques 

et avantages liés à l’utilisation de somnifères sur 

ordonnance.

• Les somnifères pris pour l’insomnie peuvent 

affecter votre conduite le lendemain matin.

• Les somnifères peuvent provoquer des effets 

secondaires rares tels que:

- Réactions allergiques sévères

- Gonflement sévère du visage

- Comportements comme passer des appels 

téléphoniques, manger, avoir des relations 

sexuelles ou conduire pendant que vous n’êtes 

pas complètement réveillé

En vente libre (Sans ordonnance)

Les somnifères en vente libre ont également des 

effets secondaires. Lisez l’étiquette d’information 

sur le médicament pour en savoir plus sur les effets 

secondaires de votre somnifère en vente libre.
Cette fiche d’information a été conçue par le Bureau de la santé des femmes de la FDA.

Pour obtenir d’autres ressources sur la santé des femmes, accédez au site

www.fda.gov/womens

2021

Problèmes de sommeil

Conseils pour mieux dormir

Apporter certains changements à vos habitudes nocturnes peut vous aider à obtenir le sommeil dont vous avez 

besoin.

• Couchez-vous et levez-vous à la même heure chaque jour.

• Dormez dans une chambre sombre et calme.

• Évitez la caféine et la nicotine.

• Ne buvez pas d’alcool avant le coucher.

• Faites quelque chose pour vous aider à vous détendre avant le coucher.

• Ne faites pas d’exercice avant le coucher.

• Ne faites pas de sieste après 15 h.

• Ne mangez pas de gros repas avant de vous coucher.

Discutez avec votre professionnel de la santé si vous avez de la difficulté à dormir 

presque toutes les nuits pendant plus de 2 semaines.

Problèmes de sommeil (FRENCH)
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 07-1475
BRAD R. JOHNSON, Plaintiff - Appellant, versus SALLIE MAE SERVICING, LP; CHRISTINE DONNELLY; MARK E. SHURE; A. ABLE; B. BAKER; C. CHARLIE; SHELLEY M. TURNER, Defendants - Appellees. Appeal from the United States District Court for the District of South Carolina, at Florence. Thomas E. Rogers, III, Magistrate Judge. (4:03-cv-03857-TER) Submitted: November 21, 2007 Decided: December 20, 2007 Before TRAXLER, KING, and SHEDD, Circuit Judges. Affirmed by unpublished per curiam opinion. Stuart M. Axelrod, AXELROD & ASSOCIATES, P.A., Myrtle Beach, South Carolina, for Appellant. James D. Cooper, Jr., C OOPER, COFFAS, MOORE & GRAY, P.A., Columbia, South Carolina, for Appellees. Unpublished opinions are not binding precedent in this circuit.* The parties consented to the magistrate judge’s jurisdiction pursuant to 28 U.S.C. § 636(c) (2000). - 2 - PER CURIAM: Brad R. Johnson appeals a magistrate judge’s order and judgment granting summary judgment to the Defendants and dismissing his complaint arising out of the revisions to a student loan repayment plan. *We have reviewed the record and the magistrate judge’s order and affirm for the reasons cited by the magistrate judge. Johnson v. Sallie Mae Servicing, LP , No. 4:03-cv-03857-TER (D.S.C. filed Mar. 28, 2007; entered Mar. 29, 2007). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
Exhibit 23.8





Consent of Independent Auditors





The Board of Directors


Kennedy-Wilson Holdings, Inc.:





We consent to the use of our report dated March 13, 2012, with respect to the combined statements of operations, members’ equity and cash flows of KWI America Multifamily, LLC and subsidiaries and KW SV Investment West Coast, LLC for the year ended December 31, 2011, incorporated by reference in the registration statements (No. 333-174742, No. 333-175002, No. 333-175559, No. 333-184752, and No. 333-192059) on Form S-3, the registration statement (No. 333-164928) on Form S-8, the registration statement (No. 333-164926) on Form S-1/A and the registration statement (No. 333-186690) on Form S-4 of Kennedy-Wilson Holdings, Inc. in reliance upon the reports of KPMG LLP, independent auditors, which report appears in amendment no. 1 to the December 31, 2013 annual report on Form 10-K of Kennedy-Wilson Holdings, Inc.








/s/ KPMG LLP


Los Angeles, California


March 31, 2014
NATIVE VILLAGE OF KIVALINA, et al., petitioners, v. EXXON MOBIL CORPORATION, et al.

No. 12-1072.

Supreme Court of the United States

May 20, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.

Justice ALITO took no part in the consideration or decision of this petition.
Travis Lee PARKER, Appellant, v. Sandi Singletary PARKER n/k/a Sandi Singletary Grant, Appellee.

No. 1D18-3572

District Court of Appeal of Florida, First District.

June 6, 2019 Rehearing Denied July 11, 2019

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
Bradley Eugene SMITH, DOC #S31121, Appellant, v. STATE of Florida, Appellee.

Case No. 2D18-2784

District Court of Appeal of Florida, Second District.

Opinion filed June 5, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
EX-31 Rule 13a-14(d)/15d-14(d) Certification.


  I, Kristen Ann Cronin, certify that:

  1.I have reviewed this report on Form 10-K and all reports on Form 10-D
    required to be filed in respect of the period covered by this report on
    Form 10-K of Deutsche Alt-A Securities Mortgage Loan Trust, Series
    2007-OA5 (the "Exchange Act periodic reports");

  2.Based on my knowledge, the Exchange Act periodic reports, taken as a
    whole, do not contain any untrue statement of a material fact or omit
    to state a material fact necessary to make the statements made, in
    light of the circumstances under which such statements were made, not
    misleading with respect to the period covered by this report;

  3.Based on my knowledge, all of the distribution, servicing and other
    information required to be provided under Form 10-D for the period
    covered by this report is included in the Exchange Act periodic reports;

  4.I am responsible for reviewing the activities performed by the
    servicer(s) and based on my knowledge and the compliance review(s)
    conducted in preparing the servicer compliance statement(s) required in
    this report under Item 1123 of Regulation AB, and except as disclosed
    in the Exchange Act periodic reports, the servicer(s) have fulfilled
    their obligations under the servicing agreement(s) in all material
    respects; and

  5.All of the reports on assessment of compliance with servicing criteria
    for asset-backed securities and their related attestation reports on
    assessment of compliance with servicing criteria for asset-backed
    securities required to be included in this report in accordance with
    Item 1122 of Regulation AB and Exchange Act Rules 13a-18 and 15d-18
    have been included as an exhibit to this report, except as otherwise
    disclosed in this report.  Any material instances of noncompliance
    described in such reports have been disclosed in this report on Form
    10-K.

    In giving the certifications above, I have reasonably relied on
    information provided to me by the following unaffiliated parties:
    Countrywide Home Loans Servicing LP as Servicer, and GMAC Mortgage,
    LLC f/k/a GMAC Mortgage Corporation as Servicer.

    Dated:   March 26, 2008


    /s/ Kristen Ann Cronin
    Signature

    Vice President
    (senior officer in charge of the servicing function of the master
    servicer)